Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Bristol-Myers Squibb Co’s current trading price is -23.91% away from its 52-week high, while its distance from the 52-week low is 12.17%. The stock’s price range during this period has varied between $42.96 and $63.33. The company, active in the Healthcare sector, saw a trading volume of around 7.85 million for the day, considerably lower average daily volume of 13.11 million observed over the last three months.
Bristol-Myers Squibb Co (BMY) currently has a stock price of $48.19. The stock saw a sharp increase in the last trading session, hitting a high of $68.0 after opening at $48.19. The lowest recorded price for the day was $34.0 before it closed at $48.44.
Bristol-Myers Squibb Co had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $63.33 on 03/11/25, while the lowest price during the same period was $42.96 on 07/31/25.
How Financial Performance Impacts Market Capitalization
Bristol-Myers Squibb Co (BMY) has experienced a quarterly rise of 3.08% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 98.09B and boasts a workforce of 34100 employees.
Decoding Analysts’ Ratings for Bristol-Myers Squibb Co
As of right now, 4 analysts are rating Bristol-Myers Squibb Co as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 19 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 48.79, with a change in price of -11.00. Similarly, Bristol-Myers Squibb Co recorded 14,246,483 in trading volume during the last 100 days, posting a change of -18.58%.
How BMY’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 2.92. Similarly, the long-term debt-to-equity ratio is also 2.64.
BMY Stock Stochastic Average
As of today, the raw stochastic average of Bristol-Myers Squibb Co over the last 50 days is at 67.05%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 82.82%. Further, the company’s Stochastic %K and %D values for the last 20 days were 82.13% and 77.61%, respectively.
BMY Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -0.45%.However, over the last six months, we can see a stronger performance of -10.59%. Over the last 30 days, the price of BMY has fallen by 1.75%. And in the last five days, it has surged by 4.92%.
